Form 4: USANA Health Sciences Director J Scott Nixon Reports Stock Transaction
SEC Form 4
J Scott Nixon, a director at USANA Health Sciences, reported a transaction involving restricted stock units on November 2, 2024.
Summary
- On November 2, 2024, J Scott Nixon, a director of USANA Health Sciences Inc., reported a transaction.
- The transaction involved the disposition of 675 common stock shares related to the vesting of restricted stock units.
- Following the transaction, Nixon directly owns 4,235 shares of common stock.
- Nixon also directly owns 1,348 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of restricted stock units, a common form of executive compensation.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the standard compensation practices for company directors.
Key Dates
| Date | Description |
|---|---|
| 11/02/2024 | Date of transaction involving restricted stock units and common stock. |
| 08/02/2024 | 25% of Restricted Stock Units vest. |
| 11/02/2024 | 25% of Restricted Stock Units vest. |
| 02/02/2025 | 25% of Restricted Stock Units vest. |
| 05/02/2025 | 25% of Restricted Stock Units vest. |
| 11/05/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.